Literature DB >> 10894673

Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides.

S Ghosh, A Panarese, A J Parker, P D Bull.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894673      PMCID: PMC1118144          DOI: 10.1136/bmj.321.7254.126

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon.

Authors:  C G Wright; W L Meyerhoff; A R Halama
Journal:  Am J Otol       Date:  1987-11

2.  Ototoxicity of topical gentamicin preparations.

Authors:  A P Bath; R M Walsh; M L Bance; J A Rutka
Journal:  Laryngoscope       Date:  1999-07       Impact factor: 3.325

3.  Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.

Authors:  J P Iaconis; D H Pitkin; W Sheikh; H L Nadler
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

4.  Treatment of chronic suppurative otitis media with topical ciprofloxacin.

Authors:  J E Dohar; C M Alper; E A Rose; W J Doyle; M L Casselbrant; M A Kenna; C D Bluestone
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-10       Impact factor: 1.547

5.  Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin.

Authors:  A Altuntas; A Aslan; N Eren; A Unal; Y Nalca
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 6.  Ototoxicity of ear drops: a clinical perspective.

Authors:  T E Linder; S Zwicky; P Brändle
Journal:  Am J Otol       Date:  1995-09

7.  Ototoxicity and topical eardrops.

Authors:  J Marais; J A Rutka
Journal:  Clin Otolaryngol Allied Sci       Date:  1998-08

8.  Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.

Authors:  J M Blondeau; M E Suter; S Borsos; C Misfeldt
Journal:  Int J Antimicrob Agents       Date:  1998-11       Impact factor: 5.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.